FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mason-Garcia, M.
Right arrow Articles by Beckman, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mason-Garcia, M.
Right arrow Articles by Beckman, B. S.

The FASEB Journal, Vol 5, 2958-2964, Copyright © 1991 by The Federation of American Societies for Experimental Biology

REVIEWS

Signal transduction in erythropoiesis

M Mason-Garcia and BS Beckman
Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana 70112.

The polypeptide hormone erythropoietin (Ep) is a growth factor whose actions on the erythroid progenitor cell induce proliferation and differentiation. The signal transduction system activated by Ep to mediate these cellular processes remains largely uncharacterized despite many years of research devoted to its elucidation. It is clear that an Ep receptor-mediated activation of adenylate cyclase or guanylate cyclase does not occur, although cAMP and cGMP may play modulatory roles. The role of calcium in the action of Ep is less clear. Although the presence of extracellular calcium seems to be an absolute requirement for Ep-induced proliferation, the positive changes induced by Ep in intracellular calcium occur with a time course suggestive of influx through ion channels opening within the cell membrane rather than release of intracellular stores by inositol trisphosphate. There is good evidence for the involvement of phospholipases A2 and C in the actions of Ep, including an early rise in lipoxygenase metabolites of arachidonic acid. Activation of phospholipase C can also result in the activation of protein kinase C in response to Ep. We present a model for the signal transduction pathway of Ep that is consistent with current knowledge and provides a framework for the coordinate actions of several intracellular mechanisms in the mediation of Ep-induced proliferation.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. S. Shin, M.-R. Chin, J. S. Kim, J.-H. Chung, C.-K. Ryu, S. Y. Jung, and D. K. Kim
Purification and Characterization of a Cytosolic, 42-kDa and Ca2+-dependent Phospholipase A2 from Bovine Red Blood Cells. ITS INVOLVEMENT IN Ca2+-DEPENDENT RELEASE OF ARACHIDONIC ACID FROM MAMMALIAN RED BLOOD CELLS
J. Biol. Chem., May 31, 2002; 277(23): 21086 - 21094.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Hanasato, M. Oka, M. Muramatsu, M. Nishino, H. Adachi, and Y. Fukuchi
E-4010, a selective phosphodiesterase 5 inhibitor, attenuates hypoxic pulmonary hypertension in rats
Am J Physiol Lung Cell Mol Physiol, August 1, 1999; 277(2): L225 - L232.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The Federation of American Societies for Experimental Biology.